Latest Period
Q1 2026
Security Snapshot
Pulmonx Corp - Common Stock (LUNG) Institutional Ownership
CUSIP: 745848101
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
110
Shares (Excl. Options)
31,697,936
Price
$1.29
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- LUNG on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 31,697,936
- Total 13F value
- $40,844,800
- Portfolio coverage rank
- 0%
- Share change
- -438,833
- Value change
- -$1,944,464
- Number of holders
- 110
- Shares outstanding
- 41,001,538
- SEC-reported price per share
- $1.20
- Insider filing price
- $1.20
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LUNG - Pulmonx Corp - Common Stock is tracked under CUSIP 745848101.
- 110 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 113 to 110 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $71,586,474 to $40,844,800.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 110 institutions filings for Q1 2026.
Security key
745848101
Latest holder period
Q1 2026
13F holders
110
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
LUNG full holder history
Pulmonx Corp SEC filings
Pulmonx Corp company facts
Pulmonx Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 745848101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
LUNG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12% | -10% | $8,029,839 | -$742,073 | 4,956,691 | -8.5% | PRIMECAP MANAGEMENT CO/CA/ | 30 Sep 2025 |
| MORGAN STANLEY | 8.5% | +12% | $17,530,110 | +$2,200,052 | 3,390,737 | +14% | Morgan Stanley | 31 Mar 2025 |
| BlackRock, Inc. | 6.8% | $13,933,140 | 2,694,998 | BlackRock, Inc. | 31 Mar 2025 | |||
| Soleus Capital Master Fund, L.P. | 6.5% | $4,344,113 | 2,665,100 | Soleus Capital Master Fund, L.P. | 06 Mar 2026 | |||
| FMR LLC | 0.2% | -104% | $114,736 | -$3,416,852 | 70,825 | -97% | FMR LLC | 31 Oct 2025 |
As of 31 Mar 2026, 110 institutional investors reported holding 31,697,936 shares of Pulmonx Corp - Common Stock (LUNG). This represents 77% of the company’s total 41,001,538 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
70%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12% | 4,724,991 | -0.06% | 0% | $6,095,238 |
| MORGAN STANLEY | 9.7% | 3,993,562 | -4% | 0% | $5,151,695 |
| Soleus Capital Management, L.P. | 6.8% | 2,788,323 | +37% | 0.15% | $3,596,937 |
| BlackRock, Inc. | 6.5% | 2,661,607 | -1.6% | 0% | $3,433,474 |
| ExodusPoint Capital Management, LP | 4.7% | 1,943,834 | -0.38% | 0.02% | $2,507,546 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 1,634,264 | 0% | 0% | $2,108,201 |
| BANK OF AMERICA CORP /DE/ | 2.8% | 1,166,826 | +60% | 0% | $1,505,206 |
| DEUTSCHE BANK AG\ | 2.8% | 1,163,678 | +3.4% | 0% | $1,501,145 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 944,492 | +4.2% | 0% | $1,218,603 |
| STATE STREET CORP | 2% | 809,116 | -1.5% | 0% | $1,043,760 |
| Stonepine Capital Management, LLC | 1.9% | 768,288 | +58% | 0.87% | $991,092 |
| Parkman Healthcare Partners LLC | 1.8% | 755,636 | +3.8% | 0.1% | $974,770 |
| BRAIDWELL LP | 1.8% | 752,541 | 0% | 0.03% | $970,778 |
| BARCLAYS PLC | 1.7% | 683,435 | +45% | 0% | $881,632 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5% | 604,455 | 0% | 0% | $779,747 |
| JPMORGAN CHASE & CO | 0.95% | 388,103 | -9.1% | 0% | $457,962 |
| ADAR1 Capital Management, LLC | 0.91% | 374,497 | +5.4% | 0.03% | $483,101 |
| AQR CAPITAL MANAGEMENT LLC | 0.87% | 357,578 | +507% | 0% | $461,276 |
| NORTHERN TRUST CORP | 0.87% | 354,674 | +5.2% | 0% | $457,529 |
| D. E. Shaw & Co., Inc. | 0.82% | 335,074 | -40% | 0% | $432,246 |
| RENAISSANCE TECHNOLOGIES LLC | 0.78% | 320,300 | +9.7% | 0% | $413,187 |
| Jefferies Financial Group Inc. | 0.7% | 285,110 | 0% | 0% | $367,792 |
| VANGUARD FIDUCIARY TRUST CO | 0.69% | 281,248 | 0% | 0% | $362,810 |
| CFM WEALTH PARTNERS LLC | 0.64% | 264,039 | 0% | 0.05% | $340,610 |
| Birchview Capital, LP | 0.61% | 250,221 | -0.14% | 0.18% | $322,785 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 31,697,936 | $40,844,800 | -$1,944,464 | $1.29 | 110 |
| 2025 Q4 | 32,396,800 | $71,586,474 | +$3,228,827 | $2.21 | 113 |
| 2025 Q3 | 31,835,122 | $51,571,453 | -$11,678,469 | $1.62 | 104 |
| 2025 Q2 | 36,256,022 | $93,898,311 | -$4,596,833 | $2.59 | 113 |
| 2025 Q1 | 36,156,132 | $243,324,576 | +$1,663,003 | $6.73 | 114 |
| 2024 Q4 | 35,870,967 | $243,565,337 | +$1,640,704 | $6.79 | 117 |
| 2024 Q3 | 35,563,337 | $293,811,542 | +$7,857,689 | $8.29 | 112 |
| 2024 Q2 | 34,744,517 | $220,280,080 | -$2,027,570 | $6.34 | 108 |
| 2024 Q1 | 34,672,382 | $321,430,455 | +$7,599,744 | $9.27 | 117 |
| 2023 Q4 | 33,520,168 | $427,381,569 | +$18,995,295 | $12.75 | 122 |
| 2023 Q3 | 33,253,122 | $343,505,198 | -$6,689,600 | $10.33 | 113 |
| 2023 Q2 | 33,869,172 | $443,992,925 | -$9,642,079 | $13.11 | 112 |
| 2023 Q1 | 34,707,575 | $388,032,205 | +$25,513,692 | $11.18 | 101 |
| 2022 Q4 | 33,773,100 | $284,706,913 | -$83,075,336 | $8.43 | 111 |
| 2022 Q3 | 34,912,391 | $581,637,070 | -$4,909,166 | $16.66 | 100 |
| 2022 Q2 | 35,341,147 | $520,187,047 | -$7,902,826 | $14.72 | 102 |
| 2022 Q1 | 34,711,340 | $861,059,885 | +$56,937,629 | $24.81 | 105 |
| 2021 Q4 | 32,045,807 | $1,027,712,027 | +$25,949,573 | $32.07 | 108 |
| 2021 Q3 | 31,600,475 | $1,136,986,158 | +$204,291,164 | $35.98 | 118 |
| 2021 Q2 | 25,771,799 | $1,136,970,052 | +$216,275,676 | $44.12 | 112 |
| 2021 Q1 | 20,788,776 | $950,879,909 | +$115,760,357 | $45.74 | 107 |
| 2020 Q4 | 17,288,638 | $1,179,671,046 | +$1,018,686,046 | $69.02 | 98 |